- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 213
Credit Saison creates impact fund
The payment services provider's Saison Ventures unit will oversee the microfinance initiative, which is targeting Southeast Asia.
Dec 12, 2020Ajinomoto gets a taste of first cohort
Coloridoh, Ellie, Hakken, Greenspoon, TechMagic and Lyxis will all join the five-month programme overseen by Ajinomoto Group Accelerator powered by 01Booster.
Dec 11, 2020Corporate venturing deal net: 7-11 December 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Dec 11, 2020Huice houses $100m in series C funding
SoftBank Ventures Asia formed part of a round that will help the retail digitalisation software provider expand overseas and grow its team.
Dec 11, 2020Infra.Market procures $20m in series B round
Sistema Asia Fund put up a share of the cash, helping to push construction industry supplies marketplace Infra.Market's overall funding to about $35m.
Dec 11, 2020Medirom seeks healthy returns in US IPO
The CCC Marketing-backed salon operator has set a range for an initial public offering set to net it between $16.8m and $19.2m.
Dec 11, 2020Obio probes Tencent for series C-plus funding
Tencent invested $15.3m in gene therapy-focused research services provider Obio Technology in its third funding round of 2020.
Dec 10, 2020Line goes to $30m Access Ventures fund
Access Ventures' second Asia-focused venture capital fund added Line Ventures and Manahusa Capital to an LP list already containing F&F and Nodo.
Dec 10, 2020MissFresh gets fed $306m
State-backed investors have provided late-stage funding for the online groceries delivery service, which is backed by Lenovo and Tencent.
Dec 10, 2020Nuance Pharma notches up $181m series D
Konruns Pharma came on board as Nuance closed a round that will fund the clinical progress of its small molecule anti-tumour drug candidate.
Dec 10, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


